Accelerate to discover
Related topics
Centrifugation of suspension cells is a problem!
Jul 8, 2020
Do you think that centrifuging cells at 500 x g is not going to cause issues? Moreover, sample prep involving...
IncuCyte webinar: Advances in 3D cell models for cancer biology
Jul 1, 2020
Get answers to your questions on 3D spheroid-based drug discovery, organoid research and working with advanced cell...
Bruker MicroCT systems supporting quality control for refurbished FFP masks
Jun 29, 2020
In the effort to tackle the coronavirus pandemic, Bruker is proud that its instruments are being used to ensure quality...
Advance your Neuro-Oncology applications with IncuCyte
Jun 25, 2020
Neuro-oncology research can benefit from robust translational in vitro models to gain greater understanding of brain...
MicroCT Applications in Lung research and Immunology
Jun 22, 2020
The ability to monitore and quantitate lung disease in real time is an advantage to using small animal microCT. Also,...
Imaging Extracellular Vescicles with super-resolution microscopy
Jun 18, 2020
Extracellular vesicles (EVs) play key roles in cell-to-cell communication. EVs can cross biological barriers (such as...
The Role of Micro-CT in Imaging Breast Cancer Specimens
Jun 17, 2020
The goal of breast cancer surgery is to remove all of the cancer with a minimum of normal tissue, but absence of full...
Cytek Northern Lights: 41 parameters with 3 lasers only
Jun 12, 2020
Cytek Biosciences Northern Lights incorporates the same innovations as the Aurora, but at a lower price point. It...
Feb 28, 2017
The authors of publication offer the MPD, a software package that automates the design of multiplex PCR primers for next-generation sequencing. The core of MPD is implemented in C for speed and uses a hashed genome to ensure primer uniqueness, avoids placing primers over sites of known variation, and efficiently pools compatible primers. A JavaScript web application (http://multiplexprimer.io) utilizing the MPD Perl package provides a convenient platform for users to make designs. Using a realistic set of genes identified by genome-wide association studies (GWAS), we achieve 90% coverage of all exonic regions using stringent design criteria. Using the first 47 primer pools for wet-lab validation, we sequenced ~25Kb at 99.7% completeness with a mean coverage of 300X among 313 samples simultaneously and identified 224 variants. The number and nature of variants we observe are consistent with high quality sequencing.
Related technologies: Target enrichment for NGS
Get more info
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
